Matches in SemOpenAlex for { <https://semopenalex.org/work/W2122188063> ?p ?o ?g. }
- W2122188063 endingPage "2266" @default.
- W2122188063 startingPage "2258" @default.
- W2122188063 abstract "OBJECTIVE Oxyntomodulin (OXM) is a glucagon-like peptide 1 (GLP-1) receptor (GLP1R)/glucagon receptor (GCGR) dual agonist peptide that reduces body weight in obese subjects through increased energy expenditure and decreased energy intake. The metabolic effects of OXM have been attributed primarily to GLP1R agonism. We examined whether a long acting GLP1R/GCGR dual agonist peptide exerts metabolic effects in diet-induced obese mice that are distinct from those obtained with a GLP1R-selective agonist. RESEARCH DESIGN AND METHODS We developed a protease-resistant dual GLP1R/GCGR agonist, DualAG, and a corresponding GLP1R-selective agonist, GLPAG, matched for GLP1R agonist potency and pharmacokinetics. The metabolic effects of these two peptides with respect to weight loss, caloric reduction, glucose control, and lipid lowering, were compared upon chronic dosing in diet-induced obese (DIO) mice. Acute studies in DIO mice revealed metabolic pathways that were modulated independent of weight loss. Studies in Glp1r−/− and Gcgr−/− mice enabled delineation of the contribution of GLP1R versus GCGR activation to the pharmacology of DualAG. RESULTS Peptide DualAG exhibits superior weight loss, lipid-lowering activity, and antihyperglycemic efficacy comparable to GLPAG. Improvements in plasma metabolic parameters including insulin, leptin, and adiponectin were more pronounced upon chronic treatment with DualAG than with GLPAG. Dual receptor agonism also increased fatty acid oxidation and reduced hepatic steatosis in DIO mice. The antiobesity effects of DualAG require activation of both GLP1R and GCGR. CONCLUSIONS Sustained GLP1R/GCGR dual agonism reverses obesity in DIO mice and is a novel therapeutic approach to the treatment of obesity." @default.
- W2122188063 created "2016-06-24" @default.
- W2122188063 creator A5003322062 @default.
- W2122188063 creator A5008921533 @default.
- W2122188063 creator A5014578145 @default.
- W2122188063 creator A5016262549 @default.
- W2122188063 creator A5017935803 @default.
- W2122188063 creator A5019902701 @default.
- W2122188063 creator A5027923313 @default.
- W2122188063 creator A5028467654 @default.
- W2122188063 creator A5037377751 @default.
- W2122188063 creator A5040533601 @default.
- W2122188063 creator A5045802340 @default.
- W2122188063 creator A5048401897 @default.
- W2122188063 creator A5056488783 @default.
- W2122188063 creator A5057685449 @default.
- W2122188063 creator A5059043247 @default.
- W2122188063 creator A5069181071 @default.
- W2122188063 creator A5069231622 @default.
- W2122188063 creator A5075553198 @default.
- W2122188063 creator A5076781411 @default.
- W2122188063 creator A5077609113 @default.
- W2122188063 creator A5077813510 @default.
- W2122188063 creator A5079444379 @default.
- W2122188063 creator A5080427293 @default.
- W2122188063 creator A5080692046 @default.
- W2122188063 date "2009-07-14" @default.
- W2122188063 modified "2023-10-02" @default.
- W2122188063 title "Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in Mice" @default.
- W2122188063 cites W1970638023 @default.
- W2122188063 cites W1983262585 @default.
- W2122188063 cites W1996286115 @default.
- W2122188063 cites W2001100563 @default.
- W2122188063 cites W2004690438 @default.
- W2122188063 cites W2006577996 @default.
- W2122188063 cites W2020597644 @default.
- W2122188063 cites W2046658782 @default.
- W2122188063 cites W2046912474 @default.
- W2122188063 cites W2049927985 @default.
- W2122188063 cites W2052693157 @default.
- W2122188063 cites W2055987651 @default.
- W2122188063 cites W2068399304 @default.
- W2122188063 cites W2068820507 @default.
- W2122188063 cites W2068876308 @default.
- W2122188063 cites W2070284998 @default.
- W2122188063 cites W2071846069 @default.
- W2122188063 cites W2081666098 @default.
- W2122188063 cites W2085330452 @default.
- W2122188063 cites W2095995901 @default.
- W2122188063 cites W2098327527 @default.
- W2122188063 cites W2098435874 @default.
- W2122188063 cites W2106833597 @default.
- W2122188063 cites W2111653877 @default.
- W2122188063 cites W2111784334 @default.
- W2122188063 cites W2115780192 @default.
- W2122188063 cites W2116862105 @default.
- W2122188063 cites W2118019244 @default.
- W2122188063 cites W2121776235 @default.
- W2122188063 cites W2127167047 @default.
- W2122188063 cites W2132144189 @default.
- W2122188063 cites W2132802847 @default.
- W2122188063 cites W2135978651 @default.
- W2122188063 cites W2138077952 @default.
- W2122188063 cites W2154497567 @default.
- W2122188063 cites W2160182855 @default.
- W2122188063 cites W2168726045 @default.
- W2122188063 cites W2169009504 @default.
- W2122188063 cites W2171857877 @default.
- W2122188063 cites W2306265054 @default.
- W2122188063 cites W2429598437 @default.
- W2122188063 cites W4233330545 @default.
- W2122188063 cites W4237377343 @default.
- W2122188063 doi "https://doi.org/10.2337/db09-0278" @default.
- W2122188063 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2750209" @default.
- W2122188063 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19602537" @default.
- W2122188063 hasPublicationYear "2009" @default.
- W2122188063 type Work @default.
- W2122188063 sameAs 2122188063 @default.
- W2122188063 citedByCount "334" @default.
- W2122188063 countsByYear W21221880632012 @default.
- W2122188063 countsByYear W21221880632013 @default.
- W2122188063 countsByYear W21221880632014 @default.
- W2122188063 countsByYear W21221880632015 @default.
- W2122188063 countsByYear W21221880632016 @default.
- W2122188063 countsByYear W21221880632017 @default.
- W2122188063 countsByYear W21221880632018 @default.
- W2122188063 countsByYear W21221880632019 @default.
- W2122188063 countsByYear W21221880632020 @default.
- W2122188063 countsByYear W21221880632021 @default.
- W2122188063 countsByYear W21221880632022 @default.
- W2122188063 countsByYear W21221880632023 @default.
- W2122188063 crossrefType "journal-article" @default.
- W2122188063 hasAuthorship W2122188063A5003322062 @default.
- W2122188063 hasAuthorship W2122188063A5008921533 @default.
- W2122188063 hasAuthorship W2122188063A5014578145 @default.
- W2122188063 hasAuthorship W2122188063A5016262549 @default.
- W2122188063 hasAuthorship W2122188063A5017935803 @default.
- W2122188063 hasAuthorship W2122188063A5019902701 @default.